Pilocarpine disposition and salivary flow responses following intravenous administration to dogs.
Oral doses of pilocarpine increase salivary flow rates in patients afflicted with xerostomia (dry mouth). This study examined the pharmacokinetics of and a pharmacodynamic response (salivation) to intravenous pilocarpine nitrate administration in dogs. Disposition was linear over a dose range of 225-600 micrograms/kg; plasma concentrations were 10-120 micrograms/L. Elimination was rapid and generally biphasic, with a terminal elimination half-life of approximately 1.3 hr. The systemic clearance of pilocarpine was high (2.22 +/- 0.49 L/kg/hr) and its steady-state volume of distribution (2.30 +/- 0.64 L/kg) was comparable to that of many other basic drugs. All doses of pilocarpine induced measurable submaxillary and parotid salivary flow rates which could be maintained constant over time. Cumulative submaxillary saliva flow was linearly related to total pilocarpine dose. Plasma pilocarpine concentration was linearly related to both steady-state and postinfusion submaxillary salivary flow rates.
Weaver
M L
ML
University of Connecticut, School of Pharmacy, Storrs 06269.
Tanzer
J M
JM
Kramer
P A
PA
D000818:Animals; D002851:Chromatography, High Pressure Liquid; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D007262:Infusions, Intravenous; D010862:Pilocarpine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology; D012044:Regression Analysis; D012469:Salivary Glands / Q000187:drug effects* / Q000378:metabolism; D012472:Salivation / Q000187:drug effects*; D014987:Xerostomia / Q000139:chemically induced / Q000209:etiology
D010862:Pilocarpine